Pasteur Institute of Iran

Signin

The Pasteur Institute of Iran

The Pasteur Institute of Iran (PII) is a medical research center located in Tehran. It is one of the oldest and most prominent research and public health centers in Iran and West Asia. The institute was established in 1920 through an agreement between the Institut Pasteur in Paris and the Iranian government. For more than a century, the Pasteur Institute of Iran has made great strides in preventing and controlling infectious diseases, gaining significant credibility and reputation both nationally and internationally.

With a total staff of more than 1,300 and five branches across the country, the institute is a leading facility in the development and manufacturing of vaccines, biopharmaceuticals, and diagnostic kits in Iran. It also functions as a major medical research hub while providing specialized health services through diagnostic laboratory services and National Reference Laboratories to control infectious diseases in Iran and neighboring countries. Moreover, the PII offers a diverse range of Ph.D. programs and educational initiatives covering medical and pharmaceutical biotechnology, microbiology, and systems biology.

Over the past century, the PII has built an essential foundation for the development of an investigative, laboratory-based biomedical culture in Iran, and its influence and contributions have spread far beyond the boundaries of its original mandate.

Senior Management Team

Annual Report on the Activities of the Pasteur Institute of Iran (2025)

The year 2025 was a period of remarkable achievement and dynamic growth for the Pasteur Institute of Iran, reinforcing its century-long legacy as a cornerstone of public health and scientific innovation in Iran and beyond. Since being trusted with the role of Director-General in February, I have overseen a year marked by strengthened international partnerships, notable scientific recognition, and a reinforced focus on national health security.

This annual report reflects our strategic expansion in global health diplomacy. We consolidated collaborations with key international partners, including the signing of a five-year cooperation agreement with Uzbekistan, advancing critical vaccine technology transfers with Cuba, and successfully exporting major shipments of BCG and Hepatitis B vaccines to Venezuela. Our global standing was further enhanced by designation as a WHO Collaborating Centre for Vector-Borne Diseases and by the active participation of our experts in pivotal Pasteur Network and WHO initiatives.

Domestically, the Pasteur Institute of Iran reaffirmed its role as a national leader in combating infectious diseases. We were entrusted with developing a national genomic surveillance system, hosted major conferences addressing threats ranging from avian influenza to antimicrobial resistance, and continued pioneering work in vaccine and diagnostic kit production. Our scientific excellence was highlighted through international accreditation of our tuberculosis laboratory, the impact factor achievement of the Iranian Biomedical Journal, and the recognition of four of our researchers among the world’s top 2% scientists.

From launching a French-language website to broaden international outreach, to training health professionals across the Islamic world, we demonstrated unwavering commitment to knowledge sharing and capacity building. This report illustrates how our historic legacy has been combined with forward-looking strategies, showcasing an institution dedicated to safeguarding public health through scientific excellence, collaboration, and innovation at both national and international levels.

I hope this report provides a clear and comprehensive picture of the recent efforts and achievements of the Pasteur Institute of Iran.